Makers Laboratories Ltd (MAKERSL) is currently trading at 189.45 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Makers Laboratories Limited (MLL) is a pharmaceutical company involved in manufacturing formulations and drug intermediates. The company has a history of strategic mergers and expansions to increase its production capacity and market presence. MLL's recent focus includes manufacturing diabetic, hypertensive treatments, and ophthalmic eye drops, indicating a strategy to diversify its product range. Modernization efforts, including upgrading its liquid injectable unit, suggest ongoing investment in expanding and enhancing production capabilities. The acquisition of Resonance Specialties Limited highlights MLL's strategic approach towards enhancing its footprint and operational scale.

Over the past 52 weeks, Makers Laboratories Ltd has traded between a low of ₹109.00 and a high of ₹236.55. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Makers Laboratories Ltd has a market capitalization of approximately 108.57. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Makers Laboratories Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 9.71 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 108.57 Cr, Makers Laboratories Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Makers Laboratories Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Makers Laboratories Ltd is 9.71. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.

Consolidated revenue from operations was ₹42.77 crore and net profit attributable to owners was ₹1.50 crore for Q1FY27 (quarter ended June 30, 2026).

Consolidated net profit attributable to owners of the parent was ₹1.50 crore for Q1FY27 (quarter ended June 30, 2026), versus ₹0.44 crore in Q1FY26.